News

Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?
Strong sales of Entresto, Kisqali, Kesimpta, Leqvio and Scemblix have likely benefited NVS' Q2 performance and offset the ...
Novartis's U.S. Business in Focus Amid Threats From Tariffs, Drug Prices -- Earnings Preview
The company's quarterly core operating profit--the company's preferred earnings metric, which strips out exceptional and other one-off items--is forecast at $5.75 billion, according to the same ...
NDTV Profit on MSN17h
Stock Recommendations Today: What Brokerages Are Saying About HCLTech, Ola Electric, Kalyan Jewellers And More
Stock recommendations today include HCLTech, Ola Electric, Kalyan Jewellers, and Sun Pharma as analysts review June quarter ...